Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combinatorial Gene Control02:33

Combinatorial Gene Control

9.5K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.5K
Conserved Binding Sites01:49

Conserved Binding Sites

5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K
RNA Interference01:23

RNA Interference

27.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.9K
RNA Splicing01:32

RNA Splicing

60.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.4K
RNA Stability01:53

RNA Stability

35.6K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.6K
Types of RNA01:23

Types of RNA

72.7K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
72.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-Scale StaphAIR: Predictive Modeling for the Diagnosis of <i>S. aureus</i> Infection via Simultaneous Detection and Quantification of Cytokines and Antibodies.

Analytical chemistry·2026
Same author

A human synovial tendon-on-a-chip models key features of peritendinous adhesions and offers a new approach methodology for testing anti-fibrotic drugs.

bioRxiv : the preprint server for biology·2026
Same author

A multi-readout photonic sensor for rapid diagnosis of Von Willebrand disease.

Npj biosensing·2026
Same author

QuickDraw: detecting HIV in whole blood using an integrated paper-based consumable that enables direct amplification of purified RNA from paper.

Lab on a chip·2026
Same author

Real-Time, Continuous Monitoring of Tissue Chips as an Emerging Opportunity for Biosensing.

Sensors (Basel, Switzerland)·2025
Same author

A Dual-Readout Photonic Sensor for Simultaneous Measurement of Enzyme Activity and Concentration.

ACS sensors·2025

Related Experiment Video

Updated: Jan 23, 2026

Novel RNA-Binding Proteins Isolation by the RaPID Methodology
11:19

Novel RNA-Binding Proteins Isolation by the RaPID Methodology

Published on: September 30, 2016

9.4K

Dynamic combinatorial chemistry as a rapid method for discovering sequence-selective RNA-binding compounds.

John D McAnany1, Benjamin L Miller2

  • 1Department of Chemistry, University of Rochester, Rochester, NY, United States.

Methods in Enzymology
|June 27, 2019
PubMed
Summary
This summary is machine-generated.

Developing sequence-selective RNA-binding molecules is crucial for disease research. Dynamic combinatorial chemistry offers a powerful strategy for designing high-affinity probes and therapeutics targeting disease-relevant RNA molecules.

Keywords:
Combinatorial chemistryDynamic combinatorial chemistryFrameshiftingHIVPeptidePeptidomimeticRNARecoding

More Related Videos

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

7.1K
PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins
12:24

PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins

Published on: July 2, 2010

54.2K

Related Experiment Videos

Last Updated: Jan 23, 2026

Novel RNA-Binding Proteins Isolation by the RaPID Methodology
11:19

Novel RNA-Binding Proteins Isolation by the RaPID Methodology

Published on: September 30, 2016

9.4K
Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

7.1K
PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins
12:24

PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins

Published on: July 2, 2010

54.2K

Area of Science:

  • Molecular Biology
  • Medicinal Chemistry
  • Chemical Biology

Background:

  • An increasing number of RNA species are implicated in human diseases.
  • There is a growing need for novel molecular probes and therapeutics targeting these RNAs.
  • Developing sequence-selective RNA-binding molecules presents a significant challenge.

Purpose of the Study:

  • To describe methods for designing, synthesizing, and screening dynamic combinatorial libraries.
  • To target disease-relevant RNA molecules using these libraries.
  • To overcome the challenge of producing high-affinity and specific RNA-binding molecules.

Main Methods:

  • Utilizing dynamic combinatorial chemistry (DCC), a fragment-based approach.
  • Employing reversible fragment combination in the presence of the target RNA.
  • Developing libraries specifically designed for RNA targets.

Main Results:

  • Demonstrated a successful approach for generating sequence-selective RNA-binding molecules.
  • Achieved high affinity and specificity for disease-relevant RNA targets.
  • Established methods for library design, synthesis, and screening.

Conclusions:

  • Dynamic combinatorial chemistry is an effective strategy for developing RNA-targeting molecules.
  • This approach facilitates the creation of novel molecular probes and therapeutics for RNA-related diseases.
  • The described methods advance the field of RNA-targeted drug discovery.